Literature DB >> 10225235

Mortality risk in selenium-deficient HIV-positive children.

A Campa1, G Shor-Posner, F Indacochea, G Zhang, H Lai, D Asthana, G B Scott, M K Baum.   

Abstract

OBJECTIVE: To determine the independent contribution of specific nutritional factors on disease progression and survival in HIV-1-infected children. POPULATION: HIV-infected children (N = 24), who were perinatally exposed to the virus and symptomatic, were recruited between October and December of 1990 from the Jackson Memorial Pediatric Immunology Clinic, Miami, Florida, and observed for 5 years.
METHODS: Immune status was measured by CD4 cell count; nutritional status was determined using serum albumin and plasma trace elements including iron, zinc, and selenium. Cox proportional hazards regression models were used to evaluate the relationship of these parameters to survival. Use of antiretroviral treatment was considered in the statistical model, and age at death was considered a parameter of disease progression.
RESULTS: Over the course of the study, 12 children died of HIV-related causes. The final Cox multivariate analysis indicated that, of the variables evaluated, only CD4 cell count below 200 (risk ratio [RR] = 7.05; 95% confidence interval [CI], 1.87-26.5); p = .004], and low levels of plasma selenium (RR = 5.96; 95% CI, 1.32-26.81; p = .02) were significantly and independently related to mortality. Among the children who died, those with low selenium levels (< or =85 microg/L), died at a younger age, suggesting more rapid disease progression.
CONCLUSIONS: In pediatric HIV-infection, low plasma level of selenium is an independent predictor of mortality, and appears to be associated with faster disease progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225235     DOI: 10.1097/00042560-199904150-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  36 in total

1.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Youth in transition: life skills among perinatally HIV-infected and HIV-exposed adolescents.

Authors:  Sarah L Pearlstein; Claude A Mellins; Curtis Dolezal; Katherine S Elkington; E Karina Santamaria; Cheng-Shiun Leu; Jennifer E Cruz; Elaine J Abrams
Journal:  J Pediatr Psychol       Date:  2013-10-11

3.  Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial.

Authors:  Rupak Shivakoti; Erin R Ewald; Nikhil Gupte; Wei-Teng Yang; Cecilia Kanyama; Sandra W Cardoso; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Richard Pollard; Barbara Detrick; Ashwin Balagopal; David M Asmuth; Richard D Semba; Thomas B Campbell; Jonathan Golub; Amita Gupta
Journal:  Clin Nutr       Date:  2018-05-29       Impact factor: 7.324

Review 4.  Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Authors:  Roy J Kim; Richard M Rutstein
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

5.  High rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, Argentina.

Authors:  Heidi B Sheehan; Jorge Benetucci; Estela Muzzio; Liliana Redini; Jorge Naveira; Marcela Segura; Mercedes Weissenbacher; Alice M Tang
Journal:  Public Health Nutr       Date:  2011-07-11       Impact factor: 4.022

Review 6.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

Review 7.  Role of selenium in HIV infection.

Authors:  Cosby A Stone; Kosuke Kawai; Roland Kupka; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2010-11       Impact factor: 7.110

8.  A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection.

Authors:  Nasim Sabery; Christopher Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009 Nov-Dec       Impact factor: 4.016

9.  Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes.

Authors:  Roland Kupka; Ferdinand Mugusi; Said Aboud; Gernard I Msamanga; Julia L Finkelstein; Donna Spiegelman; Wafaie W Fawzi
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

10.  Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults.

Authors:  Corrilynn O Hileman; Sahera Dirajlal-Fargo; Suet Kam Lam; Jessica Kumar; Craig Lacher; Gerald F Combs; Grace A McComsey
Journal:  J Nutr       Date:  2015-08-12       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.